Ozempic Causes Blindness? Patients Sue GLP-1 Drugmakers Over Rare Eye Condition Risk
The story in brief
Patients are suing drugmakers over alleged rare eye condition risk linked to GLP-1 medicines. The legal claims involve Ozempic, Wegovy, and Zepbound, with the condition being nonarteritic anterior ischemic optic neuropathy (NAION). The potential connection remains under investigation, and Eli Lilly has disputed the claims.